Author:
Chen Yuehong,Liu Feng,Chen Xinhua,Li Wenyi,Li Kejun,Cai Hailang,Wang Shunyi,Wang Honglei,Xu Ke,Zhang Chenxi,Ye Shengzhi,Shen Yunhao,Mou Tingyu,Cai Shumin,Zhou Jianwei,Yu Jiang
Abstract
Abstract
Background
Epigenetic alterations contribute greatly to the development and progression of colorectal cancer, and effect of aberrant miR-622 expression is still controversial. This study aimed to discover miR-622 regulation in CRC proliferation.
Methods
miR-622 expression and prognosis were analyzed in clinical CRC samples from Nanfang Hospital. miR-622 regulation on cell cycle and tumor proliferation was discovered, and FOLR2 was screened as functional target of miR-622 using bioinformatics analysis, which was validated via dual luciferase assay and gain-of-function and loss-of-function experiments both in vitro and in vivo.
Results
miR-622 overexpression in CRC indicated unfavorable prognosis and it regulated cell cycle to promote tumor growth both in vitro and in vivo. FOLR2 is a specific, functional target of miR-622, which negatively correlates with signature genes in cell cycle process to promote CRC proliferation.
Conclusions
miR-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation, proposing a novel mechanism and treatment target in CRC epigenetic regulation of miR-622.
Funder
Guangdong Provincial Key Labaratory of Precision Medicine for Gastrointestinal Cancer
Natural Science Foundation Regional Joint Fund of Guangdong Province, China
Medical Scientific Research Foundation of Guangdong Province, China
Natural Science Foundation of Guangdong Province of China
the Key Research and Development Program of Hebei
the President Fund of Nanfang Hospital
Publisher
Springer Science and Business Media LLC
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献